![A view of examples of medicines which parents will be told do not work on children under 12 and can even cause side effects like hallucinations Stock Photo - Alamy A view of examples of medicines which parents will be told do not work on children under 12 and can even cause side effects like hallucinations Stock Photo - Alamy](https://c8.alamy.com/comp/GBFJ5H/a-view-of-examples-of-medicines-which-parents-will-be-told-do-not-GBFJ5H.jpg)
A view of examples of medicines which parents will be told do not work on children under 12 and can even cause side effects like hallucinations Stock Photo - Alamy
![Chlorpromazine Hydrochloride Tablets for Hallucinations and Delusions - China Chlorpromazine Hydrochloride Tablets, Excitement and Agitation | Made-in-China.com Chlorpromazine Hydrochloride Tablets for Hallucinations and Delusions - China Chlorpromazine Hydrochloride Tablets, Excitement and Agitation | Made-in-China.com](https://image.made-in-china.com/2f0j00FZCiQwOrlouI/Chlorpromazine-Hydrochloride-Tablets-for-Hallucinations-and-Delusions.webp)
Chlorpromazine Hydrochloride Tablets for Hallucinations and Delusions - China Chlorpromazine Hydrochloride Tablets, Excitement and Agitation | Made-in-China.com
![FDA Approves ACADIA Pharmaceuticals' NUPLAZID™ (pimavanserin) - The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson's Disease Psychosis | Business Wire FDA Approves ACADIA Pharmaceuticals' NUPLAZID™ (pimavanserin) - The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson's Disease Psychosis | Business Wire](https://mms.businesswire.com/media/20160429006144/en/522214/5/No_Guide_Bottle_Straight_On_White.jpg)
FDA Approves ACADIA Pharmaceuticals' NUPLAZID™ (pimavanserin) - The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson's Disease Psychosis | Business Wire
![Anti-sickness drug being trialled for dementia-related hallucinations | UCL News - UCL – University College London Anti-sickness drug being trialled for dementia-related hallucinations | UCL News - UCL – University College London](https://www.ucl.ac.uk/news/sites/news/files/styles/medium_image/public/pills_3.jpg?itok=yYrXYfl3)